Sotera Health Co
SHC- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001822479
In the last 90 days, Sotera Health Co insiders filed 0 open-market purchases and 1 sale; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.21B in total; Greenlight Capital is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:22 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 14, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Revenue | $1.16B | $1.10B | $1.05B | $1.00B | $931.5M |
| Cost of revenue | $518.1M | $498.1M | $472.1M | $446.7M | $412.8M |
| Gross profit | $645.5M | $602.3M | $577.2M | $557.0M | $518.7M |
| Operating expenses | – | $304.7M | $300.5M | $308.7M | $261.9M |
| Selling, general and administrative | $252.8M | $242.6M | $236.7M | $245.7M | $198.2M |
| Operating income | – | $297.6M | $276.7M | $248.3M | $256.7M |
| Income tax | $69.6M | $69.5M | $54.7M | -$9.54M | $58.6M |
| Net income | $77.9M | $44.4M | $51.4M | -$233.6M | $116.9M |
| EPS, basic | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 |
| EPS, diluted | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 |
| Weighted shares, basic | 284.0M | 282.8M | 281.0M | 280.1M | 279.2M |
| Weighted shares, diluted | 286.4M | 284.9M | 283.2M | 280.1M | 279.4M |
| Margins and growth | |||||
| Gross margin | 55.5% | 54.7% | 55.0% | 55.5% | 55.7% |
| Operating margin | – | 27.0% | 26.4% | 24.7% | 27.6% |
| Net margin | 6.7% | 4.0% | 4.9% | -23.3% | 12.5% |
| Revenue growth, year over year | +5.7% | +4.9% | +4.5% | +7.8% | – |
| Net income growth, year over year | +75.6% | −13.6% | – | −299.8% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 14, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Cash and equivalents | $344.6M | $277.2M | $296.4M | $395.2M | $106.9M |
| Accounts receivable | $139.3M | $140.3M | $147.7M | $118.5M | $108.2M |
| Inventory | $54.4M | $49.2M | $48.3M | $37.1M | $54.3M |
| Total current assets | $613.4M | $526.0M | $557.2M | $645.0M | $346.0M |
| Goodwill | $1.10B | $1.08B | $1.11B | $1.10B | $1.12B |
| Intangible assets | $288.2M | $317.7M | $416.3M | $491.3M | $598.8M |
| Total assets | $3.26B | $3.07B | $3.13B | $3.12B | $2.79B |
| Accounts payable | $78.0M | $55.1M | $71.0M | $74.1M | $72.9M |
| Short-term debt | $14.0M | $14.8M | $4.80M | $197.1M | – |
| Total current liabilities | $249.6M | $191.0M | $230.7M | $791.6M | $161.2M |
| Long-term debt | $2.13B | $2.21B | $2.22B | $1.75B | $1.74B |
| Total liabilities | $2.66B | $2.67B | $2.69B | $2.77B | $2.20B |
| Shareholders' equity | $606.0M | $404.9M | $443.7M | $350.2M | $586.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 14, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Operating cash flow | $287.2M | $224.2M | -$147.7M | $278.0M | $281.5M |
| Capital expenditures | $138.0M | $179.1M | $215.0M | $182.4M | $102.2M |
| Free cash flow | $149.2M | $45.1M | -$362.7M | $95.6M | $179.4M |
| Depreciation and amortization | $94.9M | $84.3M | $76.6M | $64.3M | $64.2M |
| Stock-based compensation | $30.9M | $36.8M | $32.2M | $21.2M | $13.9M |
| Dividends paid | – | – | – | – | $0 |
| Share buybacks | – | – | – | $0 | $0 |
| Investing cash flow | -$135.1M | -$179.0M | -$214.9M | -$181.9M | -$159.8M |
| Financing cash flow | -$100.5M | -$50.6M | $266.0M | $197.8M | -$117.3M |
| Net change in cash | $67.6M | -$22.8M | -$94.6M | $289.4M | $4.47M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 2.7% | 3.3% | 3.1% | 2.1% | 1.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 27, 2026 | 285.6M | +0.5% | SEC |
| Jul 30, 2026 | 285.4M | +0.5% | SEC |
| Apr 28, 2026 | 285.2M | +0.5% | SEC |
| Feb 17, 2026 | 284.4M | +0.3% | SEC |
| Oct 28, 2025 | 284.1M | +0.3% | SEC |
| Jul 29, 2025 | 284.0M | +0.3% | SEC |
| Apr 25, 2025 | 283.9M | +0.3% | SEC |
| Feb 20, 2025 | 283.5M | +0.2% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.